Eavesdrop On Experts

“There just aren’t that many different ways we can think of to attack viruses.” This is according to Associate Professor Stuart Ralph, Acting Head of the Department of Biochemistry and Molecular Biology in the School of Biomedical Sciences at the University of Melbourne. “We’ve got lots and lots of drugs for parasites and bacteria, which have lots of potentially susceptible targets, but in the case of viruses – there aren’t that many things that they actually do. “So we’re limited to a handful, maybe only a dozen, discrete processes... that would cause the virus to either stop replicating or stop our bodies getting sick because they’ve got virus inside them.” Dr Craig Morton is a Senior Research Fellow, based at the Bio21 Molecular Science & Biotechnology Institute at the University of Melbourne. He says “In the case of COVID-19, [the drugs] remdesivir and dexamethasone have both been shown to have significant impacts on medical outcomes.” “Remdesivir is a drug that targets viral replication. It wasn’t